KTTA · Forms 3, 4, 5
Insider trades at Pasithea Therapeutics Corp.
No open-market insider buys or sells at Pasithea Therapeutics Corp. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Pasithea Therapeutics Corp. (KTTA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Pasithea Therapeutics Corp. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 10% owner | Buy | 100,000 | $0.53 | $53K | Form 4 | |
| Tiago Marques | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Lawrence Steinman | Director | Options or other derivatives | Form 4 | ||||
| Simon Dumesnil | Director | Options or other derivatives | Form 4 | ||||
| Daniel H Schneiderman | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Kartik Krishnan | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Emer Leahy | Director | Options or other derivatives | Form 4 | ||||
| Alfred J Novak | Director | Options or other derivatives | Form 4 | ||||
| Kartik Krishnan | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Coastlands Capital LP | 10% owner | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.